| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |